+1 (704) 266-3234

Global PCR And NGS-Based Molecular Diagnostics Market Growth (Status And Outlook) 2023-2029

Published on: Mar 2023 | From USD $2900 | Published By: LP INFORMATION INC | Number Of Pages: 101

LPI (LP Information)' newest research report, the “PCR and NGS-Based Molecular Diagnostics Industry Forecast” looks at past sales and reviews total world PCR and NGS-Based Molecular Diagnostics sales in 2022, providing a comprehensive analysis by region and market sector of projected PCR and NGS-Based Molecular Diagnostics sales for 2023 through 2029. With PCR and NGS-Based Molecular Diagnostics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world PCR and NGS-Based Molecular Diagnostics industry.
This Insight Report provides a comprehensive analysis of the global PCR and NGS-Based Molecular Diagnostics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on PCR and NGS-Based Molecular Diagnostics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global PCR and NGS-Based Molecular Diagnostics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for PCR and NGS-Based Molecular Diagnostics and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global PCR and NGS-Based Molecular Diagnostics.
The global PCR and NGS-Based Molecular Diagnostics market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for PCR and NGS-Based Molecular Diagnostics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for PCR and NGS-Based Molecular Diagnostics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for PCR and NGS-Based Molecular Diagnostics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key PCR and NGS-Based Molecular Diagnostics players cover Thermofisher, Illumine, Paragon Genomics, Roche, Qiagen, Bioo Scientific, Agilent, Pillar Biosciences and LC-Bio Technologies (Hangzhou) CO. LTD., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of PCR and NGS-Based Molecular Diagnostics market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Biomarker Discovery
Blood Sample Testig
Others
Segmentation by application
Hospitals
Academics/Research Institutions
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Thermofisher
Illumine
Paragon Genomics
Roche
Qiagen
Bioo Scientific
Agilent
Pillar Biosciences
LC-Bio Technologies (Hangzhou) CO. LTD.
iGen Technologies
Burning Rock

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global PCR and NGS-Based Molecular Diagnostics Market Size 2018-2029
2.1.2 PCR and NGS-Based Molecular Diagnostics Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 PCR and NGS-Based Molecular Diagnostics Segment by Type
2.2.1 Biomarker Discovery
2.2.2 Blood Sample Testig
2.2.3 Others
2.3 PCR and NGS-Based Molecular Diagnostics Market Size by Type
2.3.1 PCR and NGS-Based Molecular Diagnostics Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global PCR and NGS-Based Molecular Diagnostics Market Size Market Share by Type (2018-2023)
2.4 PCR and NGS-Based Molecular Diagnostics Segment by Application
2.4.1 Hospitals
2.4.2 Academics/Research Institutions
2.4.3 Others
2.5 PCR and NGS-Based Molecular Diagnostics Market Size by Application
2.5.1 PCR and NGS-Based Molecular Diagnostics Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global PCR and NGS-Based Molecular Diagnostics Market Size Market Share by Application (2018-2023)
3 PCR and NGS-Based Molecular Diagnostics Market Size by Player
3.1 PCR and NGS-Based Molecular Diagnostics Market Size Market Share by Players
3.1.1 Global PCR and NGS-Based Molecular Diagnostics Revenue by Players (2018-2023)
3.1.2 Global PCR and NGS-Based Molecular Diagnostics Revenue Market Share by Players (2018-2023)
3.2 Global PCR and NGS-Based Molecular Diagnostics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 PCR and NGS-Based Molecular Diagnostics by Regions
4.1 PCR and NGS-Based Molecular Diagnostics Market Size by Regions (2018-2023)
4.2 Americas PCR and NGS-Based Molecular Diagnostics Market Size Growth (2018-2023)
4.3 APAC PCR and NGS-Based Molecular Diagnostics Market Size Growth (2018-2023)
4.4 Europe PCR and NGS-Based Molecular Diagnostics Market Size Growth (2018-2023)
4.5 Middle East & Africa PCR and NGS-Based Molecular Diagnostics Market Size Growth (2018-2023)
5 Americas
5.1 Americas PCR and NGS-Based Molecular Diagnostics Market Size by Country (2018-2023)
5.2 Americas PCR and NGS-Based Molecular Diagnostics Market Size by Type (2018-2023)
5.3 Americas PCR and NGS-Based Molecular Diagnostics Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC PCR and NGS-Based Molecular Diagnostics Market Size by Region (2018-2023)
6.2 APAC PCR and NGS-Based Molecular Diagnostics Market Size by Type (2018-2023)
6.3 APAC PCR and NGS-Based Molecular Diagnostics Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe PCR and NGS-Based Molecular Diagnostics by Country (2018-2023)
7.2 Europe PCR and NGS-Based Molecular Diagnostics Market Size by Type (2018-2023)
7.3 Europe PCR and NGS-Based Molecular Diagnostics Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa PCR and NGS-Based Molecular Diagnostics by Region (2018-2023)
8.2 Middle East & Africa PCR and NGS-Based Molecular Diagnostics Market Size by Type (2018-2023)
8.3 Middle East & Africa PCR and NGS-Based Molecular Diagnostics Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global PCR and NGS-Based Molecular Diagnostics Market Forecast
10.1 Global PCR and NGS-Based Molecular Diagnostics Forecast by Regions (2024-2029)
10.1.1 Global PCR and NGS-Based Molecular Diagnostics Forecast by Regions (2024-2029)
10.1.2 Americas PCR and NGS-Based Molecular Diagnostics Forecast
10.1.3 APAC PCR and NGS-Based Molecular Diagnostics Forecast
10.1.4 Europe PCR and NGS-Based Molecular Diagnostics Forecast
10.1.5 Middle East & Africa PCR and NGS-Based Molecular Diagnostics Forecast
10.2 Americas PCR and NGS-Based Molecular Diagnostics Forecast by Country (2024-2029)
10.2.1 United States PCR and NGS-Based Molecular Diagnostics Market Forecast
10.2.2 Canada PCR and NGS-Based Molecular Diagnostics Market Forecast
10.2.3 Mexico PCR and NGS-Based Molecular Diagnostics Market Forecast
10.2.4 Brazil PCR and NGS-Based Molecular Diagnostics Market Forecast
10.3 APAC PCR and NGS-Based Molecular Diagnostics Forecast by Region (2024-2029)
10.3.1 China PCR and NGS-Based Molecular Diagnostics Market Forecast
10.3.2 Japan PCR and NGS-Based Molecular Diagnostics Market Forecast
10.3.3 Korea PCR and NGS-Based Molecular Diagnostics Market Forecast
10.3.4 Southeast Asia PCR and NGS-Based Molecular Diagnostics Market Forecast
10.3.5 India PCR and NGS-Based Molecular Diagnostics Market Forecast
10.3.6 Australia PCR and NGS-Based Molecular Diagnostics Market Forecast
10.4 Europe PCR and NGS-Based Molecular Diagnostics Forecast by Country (2024-2029)
10.4.1 Germany PCR and NGS-Based Molecular Diagnostics Market Forecast
10.4.2 France PCR and NGS-Based Molecular Diagnostics Market Forecast
10.4.3 UK PCR and NGS-Based Molecular Diagnostics Market Forecast
10.4.4 Italy PCR and NGS-Based Molecular Diagnostics Market Forecast
10.4.5 Russia PCR and NGS-Based Molecular Diagnostics Market Forecast
10.5 Middle East & Africa PCR and NGS-Based Molecular Diagnostics Forecast by Region (2024-2029)
10.5.1 Egypt PCR and NGS-Based Molecular Diagnostics Market Forecast
10.5.2 South Africa PCR and NGS-Based Molecular Diagnostics Market Forecast
10.5.3 Israel PCR and NGS-Based Molecular Diagnostics Market Forecast
10.5.4 Turkey PCR and NGS-Based Molecular Diagnostics Market Forecast
10.5.5 GCC Countries PCR and NGS-Based Molecular Diagnostics Market Forecast
10.6 Global PCR and NGS-Based Molecular Diagnostics Forecast by Type (2024-2029)
10.7 Global PCR and NGS-Based Molecular Diagnostics Forecast by Application (2024-2029)

11 Key Players Analysis
11.1 Thermofisher
11.1.1 Thermofisher Company Information
11.1.2 Thermofisher PCR and NGS-Based Molecular Diagnostics Product Offered
11.1.3 Thermofisher PCR and NGS-Based Molecular Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Thermofisher Main Business Overview
11.1.5 Thermofisher Latest Developments
11.2 Illumine
11.2.1 Illumine Company Information
11.2.2 Illumine PCR and NGS-Based Molecular Diagnostics Product Offered
11.2.3 Illumine PCR and NGS-Based Molecular Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Illumine Main Business Overview
11.2.5 Illumine Latest Developments
11.3 Paragon Genomics
11.3.1 Paragon Genomics Company Information
11.3.2 Paragon Genomics PCR and NGS-Based Molecular Diagnostics Product Offered
11.3.3 Paragon Genomics PCR and NGS-Based Molecular Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Paragon Genomics Main Business Overview
11.3.5 Paragon Genomics Latest Developments
11.4 Roche
11.4.1 Roche Company Information
11.4.2 Roche PCR and NGS-Based Molecular Diagnostics Product Offered
11.4.3 Roche PCR and NGS-Based Molecular Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Roche Main Business Overview
11.4.5 Roche Latest Developments
11.5 Qiagen
11.5.1 Qiagen Company Information
11.5.2 Qiagen PCR and NGS-Based Molecular Diagnostics Product Offered
11.5.3 Qiagen PCR and NGS-Based Molecular Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Qiagen Main Business Overview
11.5.5 Qiagen Latest Developments
11.6 Bioo Scientific
11.6.1 Bioo Scientific Company Information
11.6.2 Bioo Scientific PCR and NGS-Based Molecular Diagnostics Product Offered
11.6.3 Bioo Scientific PCR and NGS-Based Molecular Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Bioo Scientific Main Business Overview
11.6.5 Bioo Scientific Latest Developments
11.7 Agilent
11.7.1 Agilent Company Information
11.7.2 Agilent PCR and NGS-Based Molecular Diagnostics Product Offered
11.7.3 Agilent PCR and NGS-Based Molecular Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Agilent Main Business Overview
11.7.5 Agilent Latest Developments
11.8 Pillar Biosciences
11.8.1 Pillar Biosciences Company Information
11.8.2 Pillar Biosciences PCR and NGS-Based Molecular Diagnostics Product Offered
11.8.3 Pillar Biosciences PCR and NGS-Based Molecular Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Pillar Biosciences Main Business Overview
11.8.5 Pillar Biosciences Latest Developments
11.9 LC-Bio Technologies (Hangzhou) CO. LTD.
11.9.1 LC-Bio Technologies (Hangzhou) CO. LTD. Company Information
11.9.2 LC-Bio Technologies (Hangzhou) CO. LTD. PCR and NGS-Based Molecular Diagnostics Product Offered
11.9.3 LC-Bio Technologies (Hangzhou) CO. LTD. PCR and NGS-Based Molecular Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 LC-Bio Technologies (Hangzhou) CO. LTD. Main Business Overview
11.9.5 LC-Bio Technologies (Hangzhou) CO. LTD. Latest Developments
11.10 iGen Technologies
11.10.1 iGen Technologies Company Information
11.10.2 iGen Technologies PCR and NGS-Based Molecular Diagnostics Product Offered
11.10.3 iGen Technologies PCR and NGS-Based Molecular Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 iGen Technologies Main Business Overview
11.10.5 iGen Technologies Latest Developments
11.11 Burning Rock
11.11.1 Burning Rock Company Information
11.11.2 Burning Rock PCR and NGS-Based Molecular Diagnostics Product Offered
11.11.3 Burning Rock PCR and NGS-Based Molecular Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Burning Rock Main Business Overview
11.11.5 Burning Rock Latest Developments
12 Research Findings and Conclusion

List of Tables
Table 1. PCR and NGS-Based Molecular Diagnostics Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Biomarker Discovery
Table 3. Major Players of Blood Sample Testig
Table 4. Major Players of Others
Table 5. PCR and NGS-Based Molecular Diagnostics Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 6. Global PCR and NGS-Based Molecular Diagnostics Market Size by Type (2018-2023) & ($ Millions)
Table 7. Global PCR and NGS-Based Molecular Diagnostics Market Size Market Share by Type (2018-2023)
Table 8. PCR and NGS-Based Molecular Diagnostics Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 9. Global PCR and NGS-Based Molecular Diagnostics Market Size by Application (2018-2023) & ($ Millions)
Table 10. Global PCR and NGS-Based Molecular Diagnostics Market Size Market Share by Application (2018-2023)
Table 11. Global PCR and NGS-Based Molecular Diagnostics Revenue by Players (2018-2023) & ($ Millions)
Table 12. Global PCR and NGS-Based Molecular Diagnostics Revenue Market Share by Player (2018-2023)
Table 13. PCR and NGS-Based Molecular Diagnostics Key Players Head office and Products Offered
Table 14. PCR and NGS-Based Molecular Diagnostics Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global PCR and NGS-Based Molecular Diagnostics Market Size by Regions 2018-2023 & ($ Millions)
Table 18. Global PCR and NGS-Based Molecular Diagnostics Market Size Market Share by Regions (2018-2023)
Table 19. Global PCR and NGS-Based Molecular Diagnostics Revenue by Country/Region (2018-2023) & ($ millions)
Table 20. Global PCR and NGS-Based Molecular Diagnostics Revenue Market Share by Country/Region (2018-2023)
Table 21. Americas PCR and NGS-Based Molecular Diagnostics Market Size by Country (2018-2023) & ($ Millions)
Table 22. Americas PCR and NGS-Based Molecular Diagnostics Market Size Market Share by Country (2018-2023)
Table 23. Americas PCR and NGS-Based Molecular Diagnostics Market Size by Type (2018-2023) & ($ Millions)
Table 24. Americas PCR and NGS-Based Molecular Diagnostics Market Size Market Share by Type (2018-2023)
Table 25. Americas PCR and NGS-Based Molecular Diagnostics Market Size by Application (2018-2023) & ($ Millions)
Table 26. Americas PCR and NGS-Based Molecular Diagnostics Market Size Market Share by Application (2018-2023)
Table 27. APAC PCR and NGS-Based Molecular Diagnostics Market Size by Region (2018-2023) & ($ Millions)
Table 28. APAC PCR and NGS-Based Molecular Diagnostics Market Size Market Share by Region (2018-2023)
Table 29. APAC PCR and NGS-Based Molecular Diagnostics Market Size by Type (2018-2023) & ($ Millions)
Table 30. APAC PCR and NGS-Based Molecular Diagnostics Market Size Market Share by Type (2018-2023)
Table 31. APAC PCR and NGS-Based Molecular Diagnostics Market Size by Application (2018-2023) & ($ Millions)
Table 32. APAC PCR and NGS-Based Molecular Diagnostics Market Size Market Share by Application (2018-2023)
Table 33. Europe PCR and NGS-Based Molecular Diagnostics Market Size by Country (2018-2023) & ($ Millions)
Table 34. Europe PCR and NGS-Based Molecular Diagnostics Market Size Market Share by Country (2018-2023)
Table 35. Europe PCR and NGS-Based Molecular Diagnostics Market Size by Type (2018-2023) & ($ Millions)
Table 36. Europe PCR and NGS-Based Molecular Diagnostics Market Size Market Share by Type (2018-2023)
Table 37. Europe PCR and NGS-Based Molecular Diagnostics Market Size by Application (2018-2023) & ($ Millions)
Table 38. Europe PCR and NGS-Based Molecular Diagnostics Market Size Market Share by Application (2018-2023)
Table 39. Middle East & Africa PCR and NGS-Based Molecular Diagnostics Market Size by Region (2018-2023) & ($ Millions)
Table 40. Middle East & Africa PCR and NGS-Based Molecular Diagnostics Market Size Market Share by Region (2018-2023)
Table 41. Middle East & Africa PCR and NGS-Based Molecular Diagnostics Market Size by Type (2018-2023) & ($ Millions)
Table 42. Middle East & Africa PCR and NGS-Based Molecular Diagnostics Market Size Market Share by Type (2018-2023)
Table 43. Middle East & Africa PCR and NGS-Based Molecular Diagnostics Market Size by Application (2018-2023) & ($ Millions)
Table 44. Middle East & Africa PCR and NGS-Based Molecular Diagnostics Market Size Market Share by Application (2018-2023)
Table 45. Key Market Drivers & Growth Opportunities of PCR and NGS-Based Molecular Diagnostics
Table 46. Key Market Challenges & Risks of PCR and NGS-Based Molecular Diagnostics
Table 47. Key Industry Trends of PCR and NGS-Based Molecular Diagnostics
Table 48. Global PCR and NGS-Based Molecular Diagnostics Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 49. Global PCR and NGS-Based Molecular Diagnostics Market Size Market Share Forecast by Regions (2024-2029)
Table 50. Global PCR and NGS-Based Molecular Diagnostics Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 51. Global PCR and NGS-Based Molecular Diagnostics Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 52. Thermofisher Details, Company Type, PCR and NGS-Based Molecular Diagnostics Area Served and Its Competitors
Table 53. Thermofisher PCR and NGS-Based Molecular Diagnostics Product Offered
Table 54. Thermofisher PCR and NGS-Based Molecular Diagnostics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 55. Thermofisher Main Business
Table 56. Thermofisher Latest Developments
Table 57. Illumine Details, Company Type, PCR and NGS-Based Molecular Diagnostics Area Served and Its Competitors
Table 58. Illumine PCR and NGS-Based Molecular Diagnostics Product Offered
Table 59. Illumine Main Business
Table 60. Illumine PCR and NGS-Based Molecular Diagnostics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 61. Illumine Latest Developments
Table 62. Paragon Genomics Details, Company Type, PCR and NGS-Based Molecular Diagnostics Area Served and Its Competitors
Table 63. Paragon Genomics PCR and NGS-Based Molecular Diagnostics Product Offered
Table 64. Paragon Genomics Main Business
Table 65. Paragon Genomics PCR and NGS-Based Molecular Diagnostics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 66. Paragon Genomics Latest Developments
Table 67. Roche Details, Company Type, PCR and NGS-Based Molecular Diagnostics Area Served and Its Competitors
Table 68. Roche PCR and NGS-Based Molecular Diagnostics Product Offered
Table 69. Roche Main Business
Table 70. Roche PCR and NGS-Based Molecular Diagnostics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 71. Roche Latest Developments
Table 72. Qiagen Details, Company Type, PCR and NGS-Based Molecular Diagnostics Area Served and Its Competitors
Table 73. Qiagen PCR and NGS-Based Molecular Diagnostics Product Offered
Table 74. Qiagen Main Business
Table 75. Qiagen PCR and NGS-Based Molecular Diagnostics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 76. Qiagen Latest Developments
Table 77. Bioo Scientific Details, Company Type, PCR and NGS-Based Molecular Diagnostics Area Served and Its Competitors
Table 78. Bioo Scientific PCR and NGS-Based Molecular Diagnostics Product Offered
Table 79. Bioo Scientific Main Business
Table 80. Bioo Scientific PCR and NGS-Based Molecular Diagnostics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 81. Bioo Scientific Latest Developments
Table 82. Agilent Details, Company Type, PCR and NGS-Based Molecular Diagnostics Area Served and Its Competitors
Table 83. Agilent PCR and NGS-Based Molecular Diagnostics Product Offered
Table 84. Agilent Main Business
Table 85. Agilent PCR and NGS-Based Molecular Diagnostics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 86. Agilent Latest Developments
Table 87. Pillar Biosciences Details, Company Type, PCR and NGS-Based Molecular Diagnostics Area Served and Its Competitors
Table 88. Pillar Biosciences PCR and NGS-Based Molecular Diagnostics Product Offered
Table 89. Pillar Biosciences Main Business
Table 90. Pillar Biosciences PCR and NGS-Based Molecular Diagnostics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 91. Pillar Biosciences Latest Developments
Table 92. LC-Bio Technologies (Hangzhou) CO. LTD. Details, Company Type, PCR and NGS-Based Molecular Diagnostics Area Served and Its Competitors
Table 93. LC-Bio Technologies (Hangzhou) CO. LTD. PCR and NGS-Based Molecular Diagnostics Product Offered
Table 94. LC-Bio Technologies (Hangzhou) CO. LTD. Main Business
Table 95. LC-Bio Technologies (Hangzhou) CO. LTD. PCR and NGS-Based Molecular Diagnostics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 96. LC-Bio Technologies (Hangzhou) CO. LTD. Latest Developments
Table 97. iGen Technologies Details, Company Type, PCR and NGS-Based Molecular Diagnostics Area Served and Its Competitors
Table 98. iGen Technologies PCR and NGS-Based Molecular Diagnostics Product Offered
Table 99. iGen Technologies Main Business
Table 100. iGen Technologies PCR and NGS-Based Molecular Diagnostics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 101. iGen Technologies Latest Developments
Table 102. Burning Rock Details, Company Type, PCR and NGS-Based Molecular Diagnostics Area Served and Its Competitors
Table 103. Burning Rock PCR and NGS-Based Molecular Diagnostics Product Offered
Table 104. Burning Rock PCR and NGS-Based Molecular Diagnostics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 105. Burning Rock Main Business
Table 106. Burning Rock Latest Developments
List of Figures
Figure 1. PCR and NGS-Based Molecular Diagnostics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global PCR and NGS-Based Molecular Diagnostics Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. PCR and NGS-Based Molecular Diagnostics Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. PCR and NGS-Based Molecular Diagnostics Sales Market Share by Country/Region (2022)
Figure 8. PCR and NGS-Based Molecular Diagnostics Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global PCR and NGS-Based Molecular Diagnostics Market Size Market Share by Type in 2022
Figure 10. PCR and NGS-Based Molecular Diagnostics in Hospitals
Figure 11. Global PCR and NGS-Based Molecular Diagnostics Market: Hospitals (2018-2023) & ($ Millions)
Figure 12. PCR and NGS-Based Molecular Diagnostics in Academics/Research Institutions
Figure 13. Global PCR and NGS-Based Molecular Diagnostics Market: Academics/Research Institutions (2018-2023) & ($ Millions)
Figure 14. PCR and NGS-Based Molecular Diagnostics in Others
Figure 15. Global PCR and NGS-Based Molecular Diagnostics Market: Others (2018-2023) & ($ Millions)
Figure 16. Global PCR and NGS-Based Molecular Diagnostics Market Size Market Share by Application in 2022
Figure 17. Global PCR and NGS-Based Molecular Diagnostics Revenue Market Share by Player in 2022
Figure 18. Global PCR and NGS-Based Molecular Diagnostics Market Size Market Share by Regions (2018-2023)
Figure 19. Americas PCR and NGS-Based Molecular Diagnostics Market Size 2018-2023 ($ Millions)
Figure 20. APAC PCR and NGS-Based Molecular Diagnostics Market Size 2018-2023 ($ Millions)
Figure 21. Europe PCR and NGS-Based Molecular Diagnostics Market Size 2018-2023 ($ Millions)
Figure 22. Middle East & Africa PCR and NGS-Based Molecular Diagnostics Market Size 2018-2023 ($ Millions)
Figure 23. Americas PCR and NGS-Based Molecular Diagnostics Value Market Share by Country in 2022
Figure 24. United States PCR and NGS-Based Molecular Diagnostics Market Size Growth 2018-2023 ($ Millions)
Figure 25. Canada PCR and NGS-Based Molecular Diagnostics Market Size Growth 2018-2023 ($ Millions)
Figure 26. Mexico PCR and NGS-Based Molecular Diagnostics Market Size Growth 2018-2023 ($ Millions)
Figure 27. Brazil PCR and NGS-Based Molecular Diagnostics Market Size Growth 2018-2023 ($ Millions)
Figure 28. APAC PCR and NGS-Based Molecular Diagnostics Market Size Market Share by Region in 2022
Figure 29. APAC PCR and NGS-Based Molecular Diagnostics Market Size Market Share by Type in 2022
Figure 30. APAC PCR and NGS-Based Molecular Diagnostics Market Size Market Share by Application in 2022
Figure 31. China PCR and NGS-Based Molecular Diagnostics Market Size Growth 2018-2023 ($ Millions)
Figure 32. Japan PCR and NGS-Based Molecular Diagnostics Market Size Growth 2018-2023 ($ Millions)
Figure 33. Korea PCR and NGS-Based Molecular Diagnostics Market Size Growth 2018-2023 ($ Millions)
Figure 34. Southeast Asia PCR and NGS-Based Molecular Diagnostics Market Size Growth 2018-2023 ($ Millions)
Figure 35. India PCR and NGS-Based Molecular Diagnostics Market Size Growth 2018-2023 ($ Millions)
Figure 36. Australia PCR and NGS-Based Molecular Diagnostics Market Size Growth 2018-2023 ($ Millions)
Figure 37. Europe PCR and NGS-Based Molecular Diagnostics Market Size Market Share by Country in 2022
Figure 38. Europe PCR and NGS-Based Molecular Diagnostics Market Size Market Share by Type (2018-2023)
Figure 39. Europe PCR and NGS-Based Molecular Diagnostics Market Size Market Share by Application (2018-2023)
Figure 40. Germany PCR and NGS-Based Molecular Diagnostics Market Size Growth 2018-2023 ($ Millions)
Figure 41. France PCR and NGS-Based Molecular Diagnostics Market Size Growth 2018-2023 ($ Millions)
Figure 42. UK PCR and NGS-Based Molecular Diagnostics Market Size Growth 2018-2023 ($ Millions)
Figure 43. Italy PCR and NGS-Based Molecular Diagnostics Market Size Growth 2018-2023 ($ Millions)
Figure 44. Russia PCR and NGS-Based Molecular Diagnostics Market Size Growth 2018-2023 ($ Millions)
Figure 45. Middle East & Africa PCR and NGS-Based Molecular Diagnostics Market Size Market Share by Region (2018-2023)
Figure 46. Middle East & Africa PCR and NGS-Based Molecular Diagnostics Market Size Market Share by Type (2018-2023)
Figure 47. Middle East & Africa PCR and NGS-Based Molecular Diagnostics Market Size Market Share by Application (2018-2023)
Figure 48. Egypt PCR and NGS-Based Molecular Diagnostics Market Size Growth 2018-2023 ($ Millions)
Figure 49. South Africa PCR and NGS-Based Molecular Diagnostics Market Size Growth 2018-2023 ($ Millions)
Figure 50. Israel PCR and NGS-Based Molecular Diagnostics Market Size Growth 2018-2023 ($ Millions)
Figure 51. Turkey PCR and NGS-Based Molecular Diagnostics Market Size Growth 2018-2023 ($ Millions)
Figure 52. GCC Country PCR and NGS-Based Molecular Diagnostics Market Size Growth 2018-2023 ($ Millions)
Figure 53. Americas PCR and NGS-Based Molecular Diagnostics Market Size 2024-2029 ($ Millions)
Figure 54. APAC PCR and NGS-Based Molecular Diagnostics Market Size 2024-2029 ($ Millions)
Figure 55. Europe PCR and NGS-Based Molecular Diagnostics Market Size 2024-2029 ($ Millions)
Figure 56. Middle East & Africa PCR and NGS-Based Molecular Diagnostics Market Size 2024-2029 ($ Millions)
Figure 57. United States PCR and NGS-Based Molecular Diagnostics Market Size 2024-2029 ($ Millions)
Figure 58. Canada PCR and NGS-Based Molecular Diagnostics Market Size 2024-2029 ($ Millions)
Figure 59. Mexico PCR and NGS-Based Molecular Diagnostics Market Size 2024-2029 ($ Millions)
Figure 60. Brazil PCR and NGS-Based Molecular Diagnostics Market Size 2024-2029 ($ Millions)
Figure 61. China PCR and NGS-Based Molecular Diagnostics Market Size 2024-2029 ($ Millions)
Figure 62. Japan PCR and NGS-Based Molecular Diagnostics Market Size 2024-2029 ($ Millions)
Figure 63. Korea PCR and NGS-Based Molecular Diagnostics Market Size 2024-2029 ($ Millions)
Figure 64. Southeast Asia PCR and NGS-Based Molecular Diagnostics Market Size 2024-2029 ($ Millions)
Figure 65. India PCR and NGS-Based Molecular Diagnostics Market Size 2024-2029 ($ Millions)
Figure 66. Australia PCR and NGS-Based Molecular Diagnostics Market Size 2024-2029 ($ Millions)
Figure 67. Germany PCR and NGS-Based Molecular Diagnostics Market Size 2024-2029 ($ Millions)
Figure 68. France PCR and NGS-Based Molecular Diagnostics Market Size 2024-2029 ($ Millions)
Figure 69. UK PCR and NGS-Based Molecular Diagnostics Market Size 2024-2029 ($ Millions)
Figure 70. Italy PCR and NGS-Based Molecular Diagnostics Market Size 2024-2029 ($ Millions)
Figure 71. Russia PCR and NGS-Based Molecular Diagnostics Market Size 2024-2029 ($ Millions)
Figure 72. Spain PCR and NGS-Based Molecular Diagnostics Market Size 2024-2029 ($ Millions)
Figure 73. Egypt PCR and NGS-Based Molecular Diagnostics Market Size 2024-2029 ($ Millions)
Figure 74. South Africa PCR and NGS-Based Molecular Diagnostics Market Size 2024-2029 ($ Millions)
Figure 75. Israel PCR and NGS-Based Molecular Diagnostics Market Size 2024-2029 ($ Millions)
Figure 76. Turkey PCR and NGS-Based Molecular Diagnostics Market Size 2024-2029 ($ Millions)
Figure 77. GCC Countries PCR and NGS-Based Molecular Diagnostics Market Size 2024-2029 ($ Millions)
Figure 78. Global PCR and NGS-Based Molecular Diagnostics Market Size Market Share Forecast by Type (2024-2029)
Figure 79. Global PCR and NGS-Based Molecular Diagnostics Market Size Market Share Forecast by Application (2024-2029)

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.

Please Choose License Type

USD $2900
USD $3900
USD $4900
COVID-19
Offer

WHY US?

  • Why Us In-depth database
    Our Report’s database covers almost all topics of all regions over the Globe..
  • Why Us Recognised publishing sources
    Tie ups with top publishers around the globe.
  • Why Us Customer Support
    Complete pre and post sales support.
  • Why Us Safe & Secure
    Complete secure payment process.